Overview

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Status:
Unknown status

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The primary purpose of the study is to determine if Seneca Valley Virus may be administered safely to patients with certain types of advanced cancer.

Phase:

Phase 1

Details

Lead Sponsor:

Neotropix